The cumulative incidence was 8.9% for GLP-1 vs
But you will get better at feeling it as it happens more and more, and as you pay attention to it more
Additionally, the pleiotropic actions of GLP-1 expand the therapeutic potential of GLP-1 agonists/analogues through combination with other drug classes, suggesting new scenarios in terms of enhancing cardio-renal protection and expanding clinical indications
de Luna N, Carbayo , Dols-Icardo O, Turon-Sans J, Reyes-Leiva D, Illan-Gala I, Jeric I, Pagola-Lorz I, Lleix C, Querol L, Rubio-Guerra S, Alcolea D, Fortea J, Lle A, Corts-Vicente E, Rojas-Garcia R (2022) Neuroinflammation-related proteins NOD2 and Spp1 are abnormally upregulated in amyotrophic lateral sclerosis
At best, they may help reduce inflammation and provide temporary pain relief, but they will not address the root cause of your pain like they would for soft tissue injuries